Company/Division name | Cue Health, Inc. |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2020 |
Year reshoring implemented or to be implemented: | 2020 |
Domestically, the work will be done: | In-house |
City reshored to: | San Diego |
State(s) reshored to: | CA |
If relevant, work nearshored to: | - |
Industry(ies): | Medical Equipment & Supplies |
Product(s) reshored | cartridge-based point-of-care molecular test kits |
What domestic positive factors made reshoring more attractive? | Government Incentives, Image/brand, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training, Under-utilized capacity, Other, Covid-19 |
Government Incentive dollar amount: | $481 million |